← Open Payments lookup

MICHAEL WOLFENBARGER: Open Payments

NPI 1497474605 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,802 in 93 payments from 16 companies in 2025. Trend: 2023 $683 · 2024 $1,653 · 2025 $1,802

Food & beverage: $1,802
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.22$376
E.R. Squibb & Sons, L.L.C.11$260
ABBVIE INC.15$217
Teva Pharmaceuticals USA, Inc.7$161
Alkermes, Inc.6$141
Neurocrine BioSciences, Inc.6$131
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$92
Janssen Pharmaceuticals, Inc4$91
Takeda Pharmaceuticals U.S.A., Inc.3$81
Almatica Pharma LLC4$66

Products named: REXULTI, COBENFY, VRAYLAR, ARISTADA, INGREZZA, AUSTEDO XR, CAPLYTA, TRINTELLIX.

Industry payments across NV — which companies pay providers there.